Ambee Pharmaceuticals PLC reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 58.46 million compared to BDT 56.92 million a year ago. Net income was BDT 1.45 million compared to BDT 0.841 million a year ago. Basic earnings per share from continuing operations was BDT 0.6 compared to BDT 0.35 a year ago.
For the six months, sales was BDT 117.03 million compared to BDT 105.86 million a year ago. Net income was BDT 2.9 million compared to BDT 1.46 million a year ago. Basic earnings per share from continuing operations was BDT 1.2 compared to BDT 0.6 a year ago.